OXT and obsessive-compulsive disorder: Furthermore, intranasal oxytocin has been demonstrated to decrease positive (i.e. psychosis) symptoms in schizophrenia (see Bradley and Woolley, 2017) although there is less evidence for beneficial effects in obsessive compulsive disorder (see Bakermans-Kranenburg and van IJzendoorn, 2013).